Neurogene Inc.

Ownership Transactions Reported by 22 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+2.29 M	99.9%	$0.64	+$1.46 M
Sells	1	-1.32 K	0.1%	$0.62	-$818
Net	0	+2.28 M	99.9%		+$1.46 M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Jonathan G. Drachman	President and CEO, Director	$1.59 M			Aug 2, 2022
Rachel McMinn	Chief Executive Officer, Director	$866 K			Mar 13, 2024
Baker Bros. Advisors Lp	Director, Former 10% Owner	$287 K	+$1.46 M		Dec 18, 2023
Christine Mikail Cvijic	President and CFO	$36.6 K			Mar 13, 2024
Priti Patel	Former Chief Medical Officer	$25.9 K			Mar 31, 2023
Sean Smith	Interim CFO, Prin Acct Off	$15 K	-$818	-5.17%	Aug 10, 2023
Stuart Cobb	Chief Scientific Officer	$14.1 K			Mar 13, 2024
Erin Lavelle	Director				Jun 8, 2023
Erin M. Lavelle	Director				May 11, 2021
Martin Babler	Director				Jun 8, 2023
Robert Ho	Chief Financial Officer				Feb 1, 2022
Todd E. Simpson	Director				Jun 8, 2023
Holly Vance	General Counsel				Aug 3, 2021
Lewis T. Williams	Director				May 11, 2021
Carl Walkey	Senior Vice President				Aug 2, 2022
Donna Cochener	General Counsel, SVP Legal				Aug 2, 2022
Julie Jordan	Chief Medical Officer				Jan 16, 2024
Robert Keith Woods	Director				Jun 14, 2024
Rohan Palekar	Director				Jun 14, 2024
Cory S. Freedland	Director				Jun 14, 2024
Sarah B. Noonberg	Director				Jun 14, 2024
Robert Baffi	Director				Jun 14, 2024

Insider	Class	Transaction	%	Value $	Price $	Shares	Shares Owned	Date	Ownership